CLINICAL TRIALS PROFILE FOR HYDROCORTISONE PROBUTATE
✉ Email this page to a colleague
All Clinical Trials for HYDROCORTISONE PROBUTATE
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT01137032 ↗ | Study to Evaluate Effect of Pandel Cream 0.1% on HPA Axis in Pediatric and Adult Population | Completed | Fougera Pharmaceuticals Inc. | Phase 4 | 2004-06-01 | The purpose of this study is to determine the effect of PandelĀ® (hydrocortisone probutate cream) Cream 0.1% on the Hypothalamic Pituitary Adrenal (HPA) axis in pediatric and adult subjects with either psoriasis or atopic dermatitis involving greater than 20% body surface area. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for HYDROCORTISONE PROBUTATE
Condition Name
Clinical Trial Locations for HYDROCORTISONE PROBUTATE
Trials by Country
Clinical Trial Progress for HYDROCORTISONE PROBUTATE
Clinical Trial Phase
Clinical Trial Sponsors for HYDROCORTISONE PROBUTATE
Sponsor Name